Publications by authors named "Markus Trunzer"

7Publications

CYP3A time-dependent inhibition risk assessment validated with 400 reference drugs.

Drug Metab Dispos 2011 Jun 7;39(6):1039-46. Epub 2011 Mar 7.

Discovery ADME, Novartis Institutes for BioMedical Research, WSJ-350.3.12, P.O. Box, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
June 2011

Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.

J Med Chem 2009 Jan;52(2):329-35

Novartis Institutes for BioMedical Research, Metabolism and Pharmacokinetics, Postfach, CH-4002, Basel, Switzerland.

View Article and Find Full Text PDF
January 2009

Cytostar-T plates--a valid alternative for microplate scintillation counting of low radioactivity in combination with high-performance liquid chromatography in drug metabolism studies?

J Chromatogr A 2007 Jul 19;1157(1-2):65-72. Epub 2007 Apr 19.

Novartis Pharma AG, Metabolism and pharmacokinetics (MAP), WSJ-360.2.02, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2007

Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.

Rapid Commun Mass Spectrom 2007 ;21(6):961-70

Novartis Institutes for BioMedical Research, Metabolism and Pharmacokinetics, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
May 2007